Direct Conversion of Human Pluripotent Stem Cells to Osteoblasts With a Small Molecule

Heemin Kang, Yu Ru V. Shih, Shyni Varghese

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Human pluripotent stem cells (hPSCs), which exhibit unlimited self-renewal ability and can differentiate into all cell types in the human body, are a promising cell source for cell-based therapies and regenerative medicine. Small molecules hold great potential in the derivation of tissue-specific cells from hPSCs owing to their cost-effectiveness and scalability. Here, we describe a protocol for deriving osteoblasts from hPSCs by using a single, natural small molecule: adenosine. This simple and effective experimental protocol allows one to obtain large numbers of osteoblasts or osteoprogenitor cells, with the ability to form functional bone tissues, from hPSCs, including human embryonic stem cells and induced pluripotent stem cells. This protocol could potentially enable studies of tissue regeneration and skeletal diseases.

Original languageEnglish
Pages (from-to)1F.21.1-1F.21.6
JournalCurrent protocols in stem cell biology
Volume44
DOIs
Publication statusPublished - 2018 Feb 28
Externally publishedYes

Fingerprint

Pluripotent Stem Cells
Osteoblasts
Induced Pluripotent Stem Cells
Regenerative Medicine
Cell- and Tissue-Based Therapy
Human Body
Adenosine
Cost-Benefit Analysis
Regeneration
Bone and Bones

Keywords

  • adenosine
  • human embryonic stem cells (hESCs)
  • human induced pluripotent stem cells (hiPSCs)
  • osteogenic differentiation
  • small molecule

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

Direct Conversion of Human Pluripotent Stem Cells to Osteoblasts With a Small Molecule. / Kang, Heemin; Shih, Yu Ru V.; Varghese, Shyni.

In: Current protocols in stem cell biology, Vol. 44, 28.02.2018, p. 1F.21.1-1F.21.6.

Research output: Contribution to journalArticle

@article{33f034b4d25f49b7860b948cb91626a8,
title = "Direct Conversion of Human Pluripotent Stem Cells to Osteoblasts With a Small Molecule",
abstract = "Human pluripotent stem cells (hPSCs), which exhibit unlimited self-renewal ability and can differentiate into all cell types in the human body, are a promising cell source for cell-based therapies and regenerative medicine. Small molecules hold great potential in the derivation of tissue-specific cells from hPSCs owing to their cost-effectiveness and scalability. Here, we describe a protocol for deriving osteoblasts from hPSCs by using a single, natural small molecule: adenosine. This simple and effective experimental protocol allows one to obtain large numbers of osteoblasts or osteoprogenitor cells, with the ability to form functional bone tissues, from hPSCs, including human embryonic stem cells and induced pluripotent stem cells. This protocol could potentially enable studies of tissue regeneration and skeletal diseases.",
keywords = "adenosine, human embryonic stem cells (hESCs), human induced pluripotent stem cells (hiPSCs), osteogenic differentiation, small molecule",
author = "Heemin Kang and Shih, {Yu Ru V.} and Shyni Varghese",
year = "2018",
month = "2",
day = "28",
doi = "10.1002/cpsc.44",
language = "English",
volume = "44",
pages = "1F.21.1--1F.21.6",
journal = "Current Protocols in Stem Cell Biology",
issn = "1941-7322",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Direct Conversion of Human Pluripotent Stem Cells to Osteoblasts With a Small Molecule

AU - Kang, Heemin

AU - Shih, Yu Ru V.

AU - Varghese, Shyni

PY - 2018/2/28

Y1 - 2018/2/28

N2 - Human pluripotent stem cells (hPSCs), which exhibit unlimited self-renewal ability and can differentiate into all cell types in the human body, are a promising cell source for cell-based therapies and regenerative medicine. Small molecules hold great potential in the derivation of tissue-specific cells from hPSCs owing to their cost-effectiveness and scalability. Here, we describe a protocol for deriving osteoblasts from hPSCs by using a single, natural small molecule: adenosine. This simple and effective experimental protocol allows one to obtain large numbers of osteoblasts or osteoprogenitor cells, with the ability to form functional bone tissues, from hPSCs, including human embryonic stem cells and induced pluripotent stem cells. This protocol could potentially enable studies of tissue regeneration and skeletal diseases.

AB - Human pluripotent stem cells (hPSCs), which exhibit unlimited self-renewal ability and can differentiate into all cell types in the human body, are a promising cell source for cell-based therapies and regenerative medicine. Small molecules hold great potential in the derivation of tissue-specific cells from hPSCs owing to their cost-effectiveness and scalability. Here, we describe a protocol for deriving osteoblasts from hPSCs by using a single, natural small molecule: adenosine. This simple and effective experimental protocol allows one to obtain large numbers of osteoblasts or osteoprogenitor cells, with the ability to form functional bone tissues, from hPSCs, including human embryonic stem cells and induced pluripotent stem cells. This protocol could potentially enable studies of tissue regeneration and skeletal diseases.

KW - adenosine

KW - human embryonic stem cells (hESCs)

KW - human induced pluripotent stem cells (hiPSCs)

KW - osteogenic differentiation

KW - small molecule

UR - http://www.scopus.com/inward/record.url?scp=85047466446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047466446&partnerID=8YFLogxK

U2 - 10.1002/cpsc.44

DO - 10.1002/cpsc.44

M3 - Article

C2 - 29512108

AN - SCOPUS:85047466446

VL - 44

SP - 1F.21.1-1F.21.6

JO - Current Protocols in Stem Cell Biology

JF - Current Protocols in Stem Cell Biology

SN - 1941-7322

ER -